These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever. Jain SK Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505 [TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials]. Cryz SJ; Fürer E; Levine MM Schweiz Med Wochenschr; 1988 Apr; 118(13):467-70. PubMed ID: 3375787 [TBL] [Abstract][Full Text] [Related]
4. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. Levine MM; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C J Biotechnol; 1996 Jan; 44(1-3):193-6. PubMed ID: 8717403 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with typhoid vaccine in Thailand. Sarasombath S Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):471-4. PubMed ID: 3064324 [TBL] [Abstract][Full Text] [Related]
6. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors. Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732 [No Abstract] [Full Text] [Related]
7. Efficacy of a live oral typhoid vaccine in human volunteers. Hornick RB; DuPont HL; Levine MM; Gilman RH; Woodward WE; Snyder MJ; Woodward TE Dev Biol Stand; 1976; 33():89-92. PubMed ID: 782976 [TBL] [Abstract][Full Text] [Related]
8. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933 [TBL] [Abstract][Full Text] [Related]
9. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948 [TBL] [Abstract][Full Text] [Related]
10. The current status of typhoid vaccine development and clinical trials with typhoid vaccines. Levine MM; Tacket CO; Herrington D; Losonsky G; Murphy J; Ferreccio C Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):459-69. PubMed ID: 3064323 [TBL] [Abstract][Full Text] [Related]
12. Vaccination against typhoid fever: present status. Ivanoff B; Levine MM; Lambert PH Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143 [TBL] [Abstract][Full Text] [Related]
13. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. Tacket CO; Levine MM Clin Infect Dis; 2007 Jul; 45 Suppl 1():S20-3. PubMed ID: 17582563 [TBL] [Abstract][Full Text] [Related]
14. The development of a bivalent vaccine against diarrhoeal disease. Forrest BD Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):449-57. PubMed ID: 2464195 [TBL] [Abstract][Full Text] [Related]
15. Typhoid Vi: a less reactogenic vaccine. Cumberland NS; St Clair Roberts J; Arnold WS; Patel RK; Bowker CH J Int Med Res; 1992 Jun; 20(3):247-53. PubMed ID: 1397669 [TBL] [Abstract][Full Text] [Related]
16. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Fraser A; Paul M; Goldberg E; Acosta CJ; Leibovici L Vaccine; 2007 Nov; 25(45):7848-57. PubMed ID: 17928109 [TBL] [Abstract][Full Text] [Related]
17. The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella. Chatfield SN; Roberts M; Dougan G; Hormaeche C; Khan CM Parasitology; 1995; 110 Suppl():S17-24. PubMed ID: 7784125 [TBL] [Abstract][Full Text] [Related]